KPF
ELOS

K2 Principal Fund’s Syneron Medical Ltd ELOS Stock Holding History

K2 Principal Fund’s Portfolio ELOS Stock Details ELOS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-1,102,828
Closed -$12.1M – 469
2017
Q2 		$12.1M Buy
+1,102,828
New +$12.1M 0.8% 31

Other funds holding ELOS

BIP
Brandes Investment Partners La Jolla, California $14.1B AUM 25.52% 1-Year Est. Return
LAM
Lapides Asset Management Greenwich, Connecticut $153M AUM 9.03% 1-Year Est. Return
GLAM
Gardner Lewis Asset Management Chadds Ford, Pennsylvania $462M AUM 65.29% 1-Year Est. Return
AIM
Acrospire Investment Management Chicago, Illinois $33K AUM 23.36% 1-Year Est. Return

K2 Principal Fund's ELOS Position: Q3 2017 in Review

K2 Principal Fund sold out of Syneron Medical Ltd (ELOS) in Q3 2017, closing a stake of 1,102,828 shares — an estimated $12.1M sold.

K2 Principal Fund first reported a position in ELOS in Q2 2017 and held it in 1 quarter. The position peaked at $12.1M in Q2 2017. 4 funds tracked by Wall St. Rank hold ELOS as of Q3 2017.

  • K2 Principal Fund reported no remaining Syneron Medical Ltd position as of Q3 2017 after selling out during the quarter.
  • K2 Principal Fund sold 1,102,828 Syneron Medical Ltd shares in Q3 2017, an estimated $12.1M.
  • K2 Principal Fund first reported a position in Syneron Medical Ltd in Q2 2017 and held it in 1 quarter.
  • K2 Principal Fund's Syneron Medical Ltd position peaked at $12.1M in Q2 2017.
  • 4 funds tracked by Wall St. Rank held Syneron Medical Ltd as of Q3 2017.

Based on K2 Principal Fund's 13F filing for Q3 2017, filed 9 Nov 2017.